Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

ClinicalTrials.gov ID: NCT06456580

Public ClinicalTrials.gov record NCT06456580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study With an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of generalized myasthenia gravis.

Study identification

NCT ID
NCT06456580
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vor Biopharma
Industry
Enrollment
191 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 17, 2024 (Actual)
Primary completion
Mar 2027 (Estimated)
Completion
Jan 2029 (Estimated)
Last update posted
Oct 15, 2026

2024 – 2029

United States locations

U.S. sites
30
U.S. states
18
U.S. cities
29
Facility City State ZIP Site status
HonorHealth Neurology - Bob Bové Neuroscience Institute Scottsdale Arizona 85258 —
University of Southern California Los Angeles California 90033 —
University of California Irvine Orange California 92868 —
University of California San Francisco (UCSF) San Francisco California 94143 —
SFM Clinical Research Boca Raton Florida 33487 —
BayCare Medical Group - Clearwater Clearwater Florida 33759 —
Allied Biomedical Research Institute (ABRI) Miami Florida 33155 —
Medsol Clinical Research Center Port Charlotte Florida 33952 —
University of South Florida Health (USF Health) Tampa Florida 33613 —
Wellstar MCG Health Medical Center Augusta Georgia 30912 —
Hospital Sisters Health System Medical O'Fallon Illinois 62269 —
University of Kansas Medical Center Kansas City Kansas 66160 —
University of Kentucky Lexington Kentucky 40506 —
University of Louisville Physicians Louisville Kentucky 40202 —
Neurology Center of New England Foxborough Massachusetts 02035 —
Michigan State University Clinical Center East Lansing Michigan 48824 —
Trinity Health - Grand Rapids Hospital Grand Rapids Michigan 49503 —
UM Health Care - Neurology and Sleep Disorders Clinic Columbia Missouri 65212 —
Robert Wood Johnson University Hospital New Brunswick New Brunswick New Jersey 08901 —
Lange Neurology New York New York 10022 —
Mount Sinai Health System New York New York 10029 —
Montefiore Medical Center The Bronx New York 10467 —
University of North Carolina Hospitals - Neurology Clinic Chapel Hill North Carolina 27517 —
University of Cincinnati Health Physicians - Clifton Cincinnati Ohio 45219 —
Empower Clinical Research Tigard Oregon 97223 —
University of Tennessee Medical Center Knoxville Tennessee 37920 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Neurology Rare Disease Center Flower Mound Texas 75028 —
Houston Methodist Neurological Institute Houston Texas 77030 —
Center for Neurological Disorders, S.C. - Greenfield - Gamma Therapeutic Center Greenfield Wisconsin 53228 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 90 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06456580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06456580 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →